Our findings are consistent with the recommendation by the National Comprehensive Cancer Network (NCNN) that all breast cancer patients who are diagnosed before the age of 30 and are BRCA-negative should be offered genetic counseling and testing for TP53 [25]. The gene discussed is TP53; the disease is breast carcinoma.